Diabetes Mellitus
Conditions
Brief summary
A trial, investigating the influence of injection speed and volume on the perception of subcutaneous injection pain.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Subject has signed the informed consent form prior to screening * Age 18-74 years at screening (both included)
Exclusion criteria
* Known or suspected hypersensitivity to needle, ink ball pen or other that are in contact with the injection area during the clinical visit * Previous participation in this trial. Participation is defined as having received at least one injection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| injection pain | within 24 hours after injection |
Secondary
| Measure | Time frame |
|---|---|
| variability of injection pain | within the first 24 hours after injection |
Countries
Germany